Nanopublications LDF server

Matches in Nanopublications for { ?s ?p "[These data suggest that polymorphisms of the CYP1A2 and NAT1 genes modify the risk of pancreatic cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }

• assertion description "[These data suggest that polymorphisms of the CYP1A2 and NAT1 genes modify the risk of pancreatic cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[These data suggest that polymorphisms of the CYP1A2 and NAT1 genes modify the risk of pancreatic cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[These data suggest that polymorphisms of the CYP1A2 and NAT1 genes modify the risk of pancreatic cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[These data suggest that polymorphisms of the CYP1A2 and NAT1 genes modify the risk of pancreatic cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[These data suggest that polymorphisms of the CYP1A2 and NAT1 genes modify the risk of pancreatic cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[These data suggest that polymorphisms of the CYP1A2 and NAT1 genes modify the risk of pancreatic cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• NP217344.RAQmJgQ4vwYVjli2SORdNvAU-PBEmjIjLzmTIQNX7IaMU130_assertion description "[These data suggest that polymorphisms of the CYP1A2 and NAT1 genes modify the risk of pancreatic cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP217344.RAQmJgQ4vwYVjli2SORdNvAU-PBEmjIjLzmTIQNX7IaMU130_provenance.
• NP372506.RAf22mD469vwSd_hS7NlsT0FgRw_rh8ZL3UsauiX2eqEU130_assertion description "[These data suggest that polymorphisms of the CYP1A2 and NAT1 genes modify the risk of pancreatic cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP372506.RAf22mD469vwSd_hS7NlsT0FgRw_rh8ZL3UsauiX2eqEU130_provenance.
• NP372520.RASYULeum6w7Th55BC5GPHE9ybii_3NpB_p1jdDG6GJ4w130_assertion description "[These data suggest that polymorphisms of the CYP1A2 and NAT1 genes modify the risk of pancreatic cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP372520.RASYULeum6w7Th55BC5GPHE9ybii_3NpB_p1jdDG6GJ4w130_provenance.
• NP857800.RAUKJVwJxYY-VZHSUkg6rAHkLcYgJGUGcc698Lf2kaHvY130_assertion description "[These data suggest that polymorphisms of the CYP1A2 and NAT1 genes modify the risk of pancreatic cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP857800.RAUKJVwJxYY-VZHSUkg6rAHkLcYgJGUGcc698Lf2kaHvY130_provenance.
• NP974347.RAVPkG8-PK7f-2O9vn2Yq_BF6wQhqxeQ908IRWhhRhWiU130_assertion description "[These data suggest that polymorphisms of the CYP1A2 and NAT1 genes modify the risk of pancreatic cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP974347.RAVPkG8-PK7f-2O9vn2Yq_BF6wQhqxeQ908IRWhhRhWiU130_provenance.
• NP55341.RAl4cOOkKi2rPGZMLZ2Rn041uhO12D-vGBmKHdu-JGxNM130_assertion description "[These data suggest that polymorphisms of the CYP1A2 and NAT1 genes modify the risk of pancreatic cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP55341.RAl4cOOkKi2rPGZMLZ2Rn041uhO12D-vGBmKHdu-JGxNM130_provenance.
• NP67858.RAjWHme9PArA9QVOMUNoWzri3-PzZqJSxWFAYRxR-9Ti8130_assertion description "[These data suggest that polymorphisms of the CYP1A2 and NAT1 genes modify the risk of pancreatic cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP67858.RAjWHme9PArA9QVOMUNoWzri3-PzZqJSxWFAYRxR-9Ti8130_provenance.
• NP857808.RAp0xodIvEX2s-kbHYdruR3XkI_cQu-a2JapyCZMj8NQk130_assertion description "[These data suggest that polymorphisms of the CYP1A2 and NAT1 genes modify the risk of pancreatic cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP857808.RAp0xodIvEX2s-kbHYdruR3XkI_cQu-a2JapyCZMj8NQk130_provenance.
• NP501615.RABc9mBb9lGmFx7_AwV7FEYZR7c0sBuyNq0RuF2M_58zE130_assertion description "[These data suggest that polymorphisms of the CYP1A2 and NAT1 genes modify the risk of pancreatic cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP501615.RABc9mBb9lGmFx7_AwV7FEYZR7c0sBuyNq0RuF2M_58zE130_provenance.
• NP501620.RAD9Ppt_QhTNLr0VSm6sWO5QiFeSY8uK0jvM1wdbi92j0130_assertion description "[These data suggest that polymorphisms of the CYP1A2 and NAT1 genes modify the risk of pancreatic cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP501620.RAD9Ppt_QhTNLr0VSm6sWO5QiFeSY8uK0jvM1wdbi92j0130_provenance.
• NP217335.RAmkO_-F4s4mLMU7vfbv8leROHP0PAcDtyRd93WWRSnIA130_assertion description "[These data suggest that polymorphisms of the CYP1A2 and NAT1 genes modify the risk of pancreatic cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP217335.RAmkO_-F4s4mLMU7vfbv8leROHP0PAcDtyRd93WWRSnIA130_provenance.
• NP501617.RAb8FnN5lIb1ZlFnytF-y3g104VWnDU9ObaroPPK8-C-g130_assertion description "[These data suggest that polymorphisms of the CYP1A2 and NAT1 genes modify the risk of pancreatic cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP501617.RAb8FnN5lIb1ZlFnytF-y3g104VWnDU9ObaroPPK8-C-g130_provenance.
• NP501618.RAUctxepWFb6LgSlBkZDo2RM5kkKrmAl44NzW_Fs35u5E130_assertion description "[These data suggest that polymorphisms of the CYP1A2 and NAT1 genes modify the risk of pancreatic cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP501618.RAUctxepWFb6LgSlBkZDo2RM5kkKrmAl44NzW_Fs35u5E130_provenance.
• NP93805.RABp-6aGQYgzB0lWkx8EnR7_fBIApn_Y6snZkhx9s-lZE130_assertion description "[These data suggest that polymorphisms of the CYP1A2 and NAT1 genes modify the risk of pancreatic cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP93805.RABp-6aGQYgzB0lWkx8EnR7_fBIApn_Y6snZkhx9s-lZE130_provenance.
• NP340020.RAu33TGcYlT1ldbL_MI6tktWD3vtqlEUpzZ1PU32oZehk130_assertion description "[These data suggest that polymorphisms of the CYP1A2 and NAT1 genes modify the risk of pancreatic cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP340020.RAu33TGcYlT1ldbL_MI6tktWD3vtqlEUpzZ1PU32oZehk130_provenance.
• NP974355.RAle8iTl40RFu-KziJ_x2BWcXQHpoTMjvziuL0VFCdI7A130_assertion description "[These data suggest that polymorphisms of the CYP1A2 and NAT1 genes modify the risk of pancreatic cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP974355.RAle8iTl40RFu-KziJ_x2BWcXQHpoTMjvziuL0VFCdI7A130_provenance.
• NP501611.RAv-GUrzFkgWNXlC-4QKmeRGtBzLAVvdl9Ng7uIik2q1g130_assertion description "[These data suggest that polymorphisms of the CYP1A2 and NAT1 genes modify the risk of pancreatic cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP501611.RAv-GUrzFkgWNXlC-4QKmeRGtBzLAVvdl9Ng7uIik2q1g130_provenance.
• NP501613.RApg6Etd3n6vaOwqgK7yFegE3dfVHeOvABwuRVScqroOs130_assertion description "[These data suggest that polymorphisms of the CYP1A2 and NAT1 genes modify the risk of pancreatic cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP501613.RApg6Etd3n6vaOwqgK7yFegE3dfVHeOvABwuRVScqroOs130_provenance.
• NP501614.RAmiyaRqkKVHqChpeHGXtfT_A-PDIiVEDGXM9fY7epiqc130_assertion description "[These data suggest that polymorphisms of the CYP1A2 and NAT1 genes modify the risk of pancreatic cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP501614.RAmiyaRqkKVHqChpeHGXtfT_A-PDIiVEDGXM9fY7epiqc130_provenance.
• NP501616.RAh_IQsWNQBoyNkw5AZiCz3ul_xaoa32LlGJUtRvTNLOg130_assertion description "[These data suggest that polymorphisms of the CYP1A2 and NAT1 genes modify the risk of pancreatic cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP501616.RAh_IQsWNQBoyNkw5AZiCz3ul_xaoa32LlGJUtRvTNLOg130_provenance.
• NP340040.RA_LA9snMU3VwvhZkbSC6B4-mFX1-5293fyZjnQbmO7pY130_assertion description "[These data suggest that polymorphisms of the CYP1A2 and NAT1 genes modify the risk of pancreatic cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP340040.RA_LA9snMU3VwvhZkbSC6B4-mFX1-5293fyZjnQbmO7pY130_provenance.
• NP698066.RAPipygtpoRe4Ms_g64hPUIjKVg7EEBVqzzB8pCfDy4bY130_assertion description "[These data suggest that polymorphisms of the CYP1A2 and NAT1 genes modify the risk of pancreatic cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP698066.RAPipygtpoRe4Ms_g64hPUIjKVg7EEBVqzzB8pCfDy4bY130_provenance.
• NP698050.RAxqNqEvIER0iyUFpF_ZYbu9DcUPJ-qt8__GYZbgRVg48130_assertion description "[These data suggest that polymorphisms of the CYP1A2 and NAT1 genes modify the risk of pancreatic cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP698050.RAxqNqEvIER0iyUFpF_ZYbu9DcUPJ-qt8__GYZbgRVg48130_provenance.
• NP501612.RAItjUOdZylWTIR13--glS3CfLOs4zgUJnaSsiPPfWzl0130_assertion description "[These data suggest that polymorphisms of the CYP1A2 and NAT1 genes modify the risk of pancreatic cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP501612.RAItjUOdZylWTIR13--glS3CfLOs4zgUJnaSsiPPfWzl0130_provenance.
• NP501621.RAMGgTyyGXHZm1o1mebiNY17E8eC6Bp0pfCzksL4qTIgc130_assertion description "[These data suggest that polymorphisms of the CYP1A2 and NAT1 genes modify the risk of pancreatic cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP501621.RAMGgTyyGXHZm1o1mebiNY17E8eC6Bp0pfCzksL4qTIgc130_provenance.
• NP93803.RA9SztczdcauQUzvxpDAs_7mSGsweaAUUld_MeMfFMXns130_assertion description "[These data suggest that polymorphisms of the CYP1A2 and NAT1 genes modify the risk of pancreatic cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP93803.RA9SztczdcauQUzvxpDAs_7mSGsweaAUUld_MeMfFMXns130_provenance.
• NP501609.RA-_8BgvKLpDA5ljSdaXfNGjyvk0ojTiZSoQ9krVNK-Zs130_assertion description "[These data suggest that polymorphisms of the CYP1A2 and NAT1 genes modify the risk of pancreatic cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP501609.RA-_8BgvKLpDA5ljSdaXfNGjyvk0ojTiZSoQ9krVNK-Zs130_provenance.
• NP501619.RA-N5X9XOdyCvm10L_JPCXIFKHMrwEwjSy4WqgXFTpHjE130_assertion description "[These data suggest that polymorphisms of the CYP1A2 and NAT1 genes modify the risk of pancreatic cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP501619.RA-N5X9XOdyCvm10L_JPCXIFKHMrwEwjSy4WqgXFTpHjE130_provenance.